secwatch.observer — SEC 8-K summary
======================================

Issuer:     Arcadia Biosciences, Inc. (RKDA)
CIK:        0001469443
Form:       8-K
Filed at:   2025-11-07T23:59:59+00:00
Accession:  0001193125-25-272368
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Arcadia Q3 net income $856k vs loss $1.6M YoY; Zola YTD revenue up 26%
----------------------------------------------------------------------

- Q3 total revenue $1.30M, down 15% YoY; loss from operations $1.15M.
- Net income attributable to common $856k ($0.63 diluted EPS) vs loss $1.61M ($1.18 loss) in Q3 2024.
- Zola coconut water YTD revenue up 26% YoY; gross margin >30% for 11th straight quarter.
- Cash balance $1.12M at Sept 30, 2025; pending Roosevelt Resources combination delayed by federal shutdown.
- Recognized $4.7M credit loss on Above Food note; holds 2.7M ABVE shares valued at $3.07M.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/0001193125-25-272368-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1469443/000119312525272368/rkda-20251107.htm
  HTML page:      https://secwatch.observer/filing/0001193125-25-272368

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer